acc01351 |
Serine/threonine-protein kinase OSR1 |
phosphorylation |
Ser339 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01352 |
Large ribosomal subunit protein uL10 |
phosphorylation |
Ser307 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01353 |
Putative ribosomal protein uL10-like |
phosphorylation |
Ser307 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01354 |
Retinoblastoma-associated protein |
phosphorylation |
Ser807 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01355 |
Retinoblastoma-associated protein |
phosphorylation |
Ser811 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01356 |
Nucleophosmin |
phosphorylation |
Ser70 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01357 |
Heat shock protein HSP 90-alpha |
phosphorylation |
Ser263 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01358 |
Heterogeneous nuclear ribonucleoproteins C1/C2 |
phosphorylation |
Ser253 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01359 |
Heat shock protein HSP 90-beta |
phosphorylation |
Ser261 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01360 |
Putative heat shock protein HSP 90-beta 2 |
phosphorylation |
Ser183 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01361 |
U1 small nuclear ribonucleoprotein 70 kDa |
phosphorylation |
Ser226 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01362 |
Nuclear factor 1 C-type |
phosphorylation |
Ser323 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01363 |
Microtubule-associated protein tau |
phosphorylation |
Ser713 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01364 |
Microtubule-associated protein 2 |
phosphorylation |
Ser285 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01365 |
DNA topoisomerase 2-alpha |
phosphorylation |
Ser1332 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01366 |
DNA topoisomerase 2-alpha |
phosphorylation |
Ser1354 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01367 |
DNA topoisomerase 2-alpha |
phosphorylation |
Ser1471 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01368 |
DNA topoisomerase 2-alpha |
phosphorylation |
Ser1474 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01369 |
DNA topoisomerase 2-alpha |
phosphorylation |
Ser1525 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01370 |
Cation-independent mannose-6-phosphate receptor |
phosphorylation |
Ser2484 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01371 |
cAMP-dependent protein kinase type II-alpha regulatory subunit |
phosphorylation |
Ser78 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01372 |
cAMP-dependent protein kinase type II-alpha regulatory subunit |
phosphorylation |
Ser80 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01373 |
Pyruvate kinase PKM |
phosphorylation |
Ser37 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01374 |
Endoplasmin |
phosphorylation |
Ser306 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01375 |
CD44 antigen |
phosphorylation |
Ser706 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01376 |
Histone H1.5 |
phosphorylation |
Ser18 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01377 |
Transcription factor JunD |
phosphorylation |
Ser255 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01378 |
Transcription factor JunD |
phosphorylation |
Ser259 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01379 |
Regulator of chromosome condensation |
phosphorylation |
Ser11 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01380 |
DNA repair protein XRCC1 |
phosphorylation |
Ser409 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01381 |
Sodium/hydrogen exchanger 1 |
phosphorylation |
Ser785 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01382 |
Cyclin-dependent kinase 11A |
phosphorylation |
Ser740 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01383 |
Cyclin-dependent kinase 11B |
phosphorylation |
Ser752 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01384 |
Voltage-dependent anion-selective channel protein 1 |
phosphorylation |
Ser104 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01385 |
Oxysterol-binding protein 1 |
phosphorylation |
Ser190 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01386 |
Elongation factor 1-beta |
phosphorylation |
Ser106 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01387 |
DNA replication licensing factor MCM3 |
phosphorylation |
Ser672 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01388 |
Transcriptional repressor protein YY1 |
phosphorylation |
Ser247 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01389 |
Microtubule-associated protein 4 |
phosphorylation |
Ser280 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01390 |
Microtubule-associated protein 4 |
phosphorylation |
Ser507 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01391 |
Microtubule-associated protein 4 |
phosphorylation |
Ser510 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01392 |
Calnexin |
phosphorylation |
Ser554 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01393 |
Myristoylated alanine-rich C-kinase substrate |
phosphorylation |
Ser170 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01394 |
Heterogeneous nuclear ribonucleoprotein H3 |
phosphorylation |
Ser216 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01395 |
Heterogeneous nuclear ribonucleoprotein H |
phosphorylation |
Ser104 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01396 |
"Heterogeneous nuclear ribonucleoprotein H, N-terminally processed" |
phosphorylation |
Ser104 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01397 |
Protein DEK |
phosphorylation |
Ser32 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01398 |
Protein DEK |
phosphorylation |
Ser301 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01399 |
Protein DEK |
phosphorylation |
Ser303 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01400 |
Large ribosomal subunit protein uL4 |
phosphorylation |
Ser295 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|